Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Yun-Bo Yan"'
Autor:
Si-Jia Huang, Jing Huang, Yun-Bo Yan, Jiao Qiu, Rui-Qiao Tan, Yu Liu, Qing Tian, Li Guan, Shuai-Shuai Niu, Yanxiang Zhang, Zhijiang Xi, Ying Xiang, Quan Gong
Publikováno v:
Renal Failure, Vol 42, Iss 1, Pp 350-357 (2020)
Background Nephrotoxicity, especially acute kidney injury (AKI), is the main dose-limiting toxicity of cisplatin. Although recent studies showed that curcumin prevented cisplatin-induced AKI effectively, further studies to understand the mechanism ar
Externí odkaz:
https://doaj.org/article/d461e697fb8244c7b4cedd101f693cab
Antitumor effects and molecular mechanisms of action of natural products in ovarian cancer (Review).
Publikováno v:
Oncology Letters. Nov2020, Vol. 20 Issue 5, p1-15. 15p.
Autor:
Jing Huang, Si-Jia Huang, Shuai-Shuai Niu, Yun-Bo Yan, Ying Xiang, Yu Liu, Qing Tian, Rui-Qiao Tan, Li Guan, Jiao Qiu
Publikováno v:
Yangtze Medicine. :12-22
Background: Cisplatin, a chemotherapeutic agent, is widely used in the treatment of malignant tumors. Nephrotoxicity, especially acute kidney injury (AKI), is the most common and severe adverse reaction of cisplatin. Resveratrol and ginsenoside Rg1,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::710f49b42b0bfc49e4cdec6491680730
https://doi.org/10.4236/ym.2021.51002
https://doi.org/10.4236/ym.2021.51002
Autor:
Yanxiang Zhang, Ying Xiang, Si-Jia Huang, Quan Gong, Jing Huang, Yu Liu, Zhijiang Xi, Yun-Bo Yan, Jiao Qiu, Li Guan, Rui-Qiao Tan, Qing Tian, Shuai-Shuai Niu
Publikováno v:
Renal Failure
Renal Failure, Vol 42, Iss 1, Pp 350-357 (2020)
Renal Failure, Vol 42, Iss 1, Pp 350-357 (2020)
Background: Nephrotoxicity, especially acute kidney injury (AKI), is the main dose-limiting toxicity of cisplatin. Although recent studies showed that curcumin prevented cisplatin-induced AKI effectively, further studies to understand the mechanism a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8bf09da5a666d051cf0a144a25d79b3
https://doi.org/10.1080/0886022x.2020.1751658
https://doi.org/10.1080/0886022x.2020.1751658
Publikováno v:
Oncology Letters
Ovarian cancer is a common malignancy and the second leading cause of mortality among females with genital tract cancer. At present, postoperative platinum drugs and paclitaxel-based chemotherapy is the gold standard treatment for ovarian cancer. How
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24fcaad7ccbbf5445cd5553530cfda34
http://europepmc.org/articles/PMC7471673
http://europepmc.org/articles/PMC7471673
Autor:
Yun-Bo Yang, Bin-Chao Huang
Publikováno v:
Discrete Dynamics in Nature and Society, Vol 2024 (2024)
In this article, a subgrid-sparse-grad-div method for incompressible flow problem was proposed, which is a combination of the subgrid stabilization method and the recently proposed sparse-grad-div method. The method maintains the advantage of both me
Externí odkaz:
https://doaj.org/article/fa840f9a2ef04a848dddd204b3aa487c
Autor:
Hai-chao Liu, Yun-bo Yang, Peng Zhang, Jia-xing Zhang, Zhi-sheng Pei, Bo-wen Chen, Gui-qian Liu, Hui Li
Publikováno v:
Italian Journal of Pediatrics, Vol 49, Iss 1, Pp 1-6 (2023)
Abstract Background To investigate the efficacy and safety of endoscopic electrocoagulation haemostasis via a percutaneous transhepatic approach for the treatment of grade IV haemorrhagic cystitis (HC) after allogeneic haematopoietic stem cell transp
Externí odkaz:
https://doaj.org/article/479bd71adef9416daf7fc16559bbcf56
Autor:
Li Qin, Yun-Bo Yang, Yi-Xin Yang, Yong-Zhen Gong, Xiao-Ling Li, Gui-Yuan Li, Hong-Dan Luo, Xue-Jiao Xie, Xi-Long Zheng, Duan-Fang Liao
Publikováno v:
Journal of Pharmacological Sciences, Vol 125, Iss 3, Pp 283-291 (2014)
Abstract.: Proliferation of vascular smooth muscle cells (VSMCs) contributes to the development of atherosclerosis. Ezetimibe is a new lipid lowering agent that inhibits cholesterol absorption. In the present study we attempted to investigate whether
Externí odkaz:
https://doaj.org/article/88aa9056784f457184d7f5f5146198d4